Page last updated: 2024-11-02

oxidopamine and Chromosomal Translocation

oxidopamine has been researched along with Chromosomal Translocation in 2 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
He, X1
Yuan, W1
Li, Z1
Hou, Y1
Liu, F1
Feng, J1
Monti, B1
Polazzi, E1
Batti, L1
Crochemore, C1
Virgili, M1
Contestabile, A1

Other Studies

2 other studies available for oxidopamine and Chromosomal Translocation

ArticleYear
6-Hydroxydopamine induces autophagic flux dysfunction by impairing transcription factor EB activation and lysosomal function in dopaminergic neurons and SH-SY5Y cells.
    Toxicology letters, 2018, Volume: 283

    Topics: Animals; Apoptosis; Autophagy; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Cell Lin

2018
Alpha-synuclein protects cerebellar granule neurons against 6-hydroxydopamine-induced death.
    Journal of neurochemistry, 2007, Volume: 103, Issue:2

    Topics: alpha-Synuclein; Animals; Apoptosis; Blotting, Western; Cell Death; Cell Nucleus; Cell Survival; Cer

2007